Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Where New York hedge fund managers find investment opportunities

Wednesday, October 31, 2012

Benedicte Gravrand, Opalesque Geneva:

Where do fund managers see opportunity these days? Participants at the recent Opalesque New York Roundtable mentioned strategies such as long/short equity, merger arbitrage, event driven, and prospects in structured credit, pharma, European volatility, emerging markets and niche products. So a lot to chose from.

When looking around at what to invest in and how to invest, things don’t look so great in general, Matthew Denning told the Roundtable. "Many markets have been trend-less, creating issues for macro funds and various asset classes. Then spikes of volatility have been torturing those same trading strategies. It is very tough to get bullish in general within credit given where we are in the cycle…" Denning is senior Research Analyst at PineBridge Investments, a $68bn asset manager that runs FoFs.

Equity long/short hedge funds may have returned "disappointing" performance so far this year, but he still sees a lot of opportunity in that strategy. The Hennessee Long/Short Equity Index is up 5% YTD (to end-Sept.).

"We feel that this year has actually been a pretty conducive environment to investing compared to the last three or four years," he said. "The excuses that some of the equity managers have given before – about corr......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its